Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:06 PM ET 8-K
Capital Raise FibroBiologics, Inc. FBLG

FibroBiologics Capital Raise of $500K

FibroBiologics closed a $0.5 million private placement with its Chief Scientific Officer, Hamid Khoja, Ph.D., for the purchase of 298,508 shares and accompanying warrants. The securities were sold at a combined purchase price of $1.675 per unit, with proceeds intended for general corporate purposes and working capital. Additionally, shareholders approved the issuance of over 8 million shares related to a prior June 2026 securities purchase agreement.

Value
$500K
Counterparty
Hamid Khoja, Ph.D.
4:06 PM ET 8-K
Leadership Change Saratoga Investment Corp. SAR

Saratoga Investment Leadership Change

Henri J. Steenkamp is stepping down as CFO, Chief Compliance Officer, Treasurer, and Secretary effective October 31, 2026, for health-related reasons, though he will remain on the Board and serve as a consultant. The company promoted Christine Ramdihal to Chief Accounting Officer and Treasurer (Principal Financial Officer) and Rochelle Kracoff to Chief Compliance Officer and Secretary to fill the roles.

4:06 PM ET 8-K
M&A Deal Beazer Homes USA Inc BZH

Beazer Homes USA M&A Deal with Dream Finders Homes, Inc.

Beazer Homes USA entered into supplemental indentures for its 2031 and 2032 senior notes following a successful consent solicitation by Dream Finders Homes. The amendments redefine 'Change of Control' to ensure the pending merger between the two companies does not trigger debt repayment obligations. This update provides a material status update on the regulatory and structural progress of the previously announced merger.

Counterparty
Dream Finders Homes, Inc.
4:05 PM ET 8-K
Leadership Change Inve Technologies, Inc. INVE

Inve Technologies Leadership Change

INVE Technologies appointed James Greenwell as Interim Chief Executive Officer, effective September 21, 2026, following the resignation of Kirsten Newquist. The company will pay executive search firm Korn Ferry approximately $18,000 per week for Mr. Greenwell's services under a statement of work expected to run through March 2027.

Counterparty
James Greenwell
Term
through March 26, 2027
4:05 PM ET 8-K
Shareholder Meeting 20/20 Biolabs, Inc. AIDX

20/20 Biolabs Shareholder Meeting

20/20 Biolabs, Inc. reported the results of its adjourned annual meeting of stockholders held on September 16, 2026. Stockholders approved a charter amendment to increase the number of authorized shares of common stock from 50 million to 500 million shares.

4:05 PM ET 8-K
Loan & Debt Americas Carmart Inc CRMT

Americas Carmart Debt Financing Update with Silver Point Finance, LLC

America's Car-Mart, Inc. entered into a third extension of its limited waiver and amendment to its Credit and Guaranty Agreement with Silver Point Finance, extending the termination date to September 24, 2026. The extension provides temporary relief from minimum liquidity and collateral coverage ratio requirements while the company continues to evaluate strategic alternatives and address existing or anticipated events of default. The company is currently in active discussions with third parties regarding potential financing, recapitalization, or restructuring transactions.

Counterparty
Silver Point Finance, LLC
Term
through September 24, 2026
4:05 PM ET Form 4
Insider Selling Palvella Therapeutics, Inc. PVLA

Palvella Therapeutics COO Kathleen Goin Sells $655K of Stock

Kathleen Goin, COO, sold 4,302 shares of Palvella Therapeutics, Inc. at $151.16 to $153.24 a share (average $152.24) in 3 transactions, worth $655K in total on Sep 16, 2026. Shares held after the trade: 0 (-100.0%).

Value
$655K
Shares
4,302
Average price
$152.24
Role
COO
Holding change
-100.0%
Trade date
Sep 16, 2026
4:05 PM ET Form 4
Insider Selling Quicklogic Corp QUIK

Quicklogic Sr. VP and CTO Timothy Saxe Sells $106K of Stock

Timothy Saxe, Sr. VP and CTO, sold 10,364 shares of Quicklogic Corp at $10.21 a share, worth $106K in total on Sep 17, 2026. Shares held after the trade: 152,214 (-6.4%).

Value
$106K
Shares
10,364
Price
$10.21
Role
Sr. VP and CTO
Holding change
-6.4%
Trade date
Sep 17, 2026
4:05 PM ET Form 4
Insider Selling Quicklogic Corp QUIK

Quicklogic President and CEO Brian C. Faith Sells $176K of Stock

Brian C. Faith, President and CEO, sold 17,255 shares of Quicklogic Corp at $10.21 a share, worth $176K in total on Sep 17, 2026. Shares held after the trade: 271,065 (-6.0%).

Value
$176K
Shares
17,255
Price
$10.21
Role
President and CEO
Holding change
-6.0%
Trade date
Sep 17, 2026
4:05 PM ET Form 4
Insider Selling Ethos Technologies Inc. LIFE

Ethos Technologies CEO and Secretary Peter George Colis Sells $2.7M of Stock

Peter George Colis, CEO and Secretary, sold 70,000 shares of Ethos Technologies Inc. at $35.98 to $40.35 a share (average $38.51) in 8 transactions, worth $2.7M in total between Sep 16, 2026 and Sep 18, 2026. Shares held after the trade: 1,543,855 (-0.6%).

Value
$2.7M
Shares
70,000
Average price
$38.51
Role
CEO and Secretary
Holding change
-0.6%
Trade date
Sep 16, 2026 to Sep 18, 2026
4:05 PM ET Form 4
Insider Selling Quicklogic Corp QUIK

Quicklogic CFO, SVP Finance Elias Nader Sells $84.7K of Stock

Elias Nader, CFO, SVP Finance, sold 8,291 shares of Quicklogic Corp at $10.21 a share, worth $84.7K in total on Sep 17, 2026. Shares held after the trade: 88,845 (-8.5%).

Value
$84.7K
Shares
8,291
Price
$10.21
Role
CFO, SVP Finance
Holding change
-8.5%
Trade date
Sep 17, 2026
4:05 PM ET Form 4
Insider Selling Ethos Technologies Inc. LIFE

Ethos Technologies President Lingke Wang Sells $4.61M of Stock

Lingke Wang, President, sold 118,333 shares of Ethos Technologies Inc. at $38.36 to $39.67 a share (average $38.96) in 3 transactions, worth $4.61M in total on Sep 17, 2026. Shares held after the trade: 1,537,543 (-0.0%).

Value
$4.61M
Shares
118,333
Average price
$38.96
Role
President
Holding change
-0.0%
Trade date
Sep 17, 2026
4:05 PM ET Form 4
Insider Selling Magnite, Inc. MGNI

Magnite Insider Douglas S. Knopper Sells $981K of Stock

Douglas S. Knopper sold 37,337 shares of Magnite, Inc. at $26.28 a share, worth $981K in total on Sep 17, 2026. Shares held after the trade: 51,136 (-42.2%).

Value
$981K
Shares
37,337
Price
$26.28
Holding change
-42.2%
Trade date
Sep 17, 2026
4:05 PM ET Form 4
Insider Selling Revvity, Inc. RVTY

Revvity Please See Remarks Tajinder S. Vohra Sells $1.03M of Stock

Tajinder S. Vohra, Please See Remarks, sold 7,330 shares of Revvity, Inc. at $140.88 a share, worth $1.03M in total on Sep 16, 2026. Shares held after the trade: 6,635 (-52.5%).

Value
$1.03M
Shares
7,330
Price
$140.88
Role
Please See Remarks
Holding change
-52.5%
Trade date
Sep 16, 2026
4:04 PM ET Form 4
Insider Selling 3D Systems Corp DDD

3D Systems President and CEO Jeffrey A. Graves Sells $152K of Stock

Jeffrey A. Graves, President and CEO, sold 42,686 shares of 3D Systems Corp at $3.55 a share, worth $152K in total on Sep 17, 2026. Shares held after the trade: 1,231,596 (-3.3%).

Value
$152K
Shares
42,686
Price
$3.55
Role
President and CEO
Holding change
-3.3%
Trade date
Sep 17, 2026
4:03 PM ET Form 4
Insider Selling Crescent Biopharma, Inc. CBIO

Crescent Biopharma CMO Ellie Eunkyung Im Sells $11.2K of Stock

Ellie Eunkyung Im, CMO, sold 623 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $11.2K in total on Sep 16, 2026. Shares held after the trade: 21,446 (-2.8%).

Value
$11.2K
Shares
623
Price
$17.90
Role
CMO
Holding change
-2.8%
Trade date
Sep 16, 2026
4:03 PM ET Form 4
Insider Selling Crescent Biopharma, Inc. CBIO

Crescent Biopharma President and COO Jonathan McNeill Sells $77.2K of Stock

Jonathan McNeill, President and COO, sold 4,570 shares of Crescent Biopharma, Inc. at $16.71 to $17.90 a share (average $16.90) in 2 transactions, worth $77.2K in total between Sep 16, 2026 and Sep 18, 2026. Shares held after the trade: 134,588 (-2.8%).

Value
$77.2K
Shares
4,570
Average price
$16.90
Role
President and COO
Holding change
-2.8%
Trade date
Sep 16, 2026 to Sep 18, 2026
4:03 PM ET Form 4
Insider Selling Crescent Biopharma, Inc. CBIO

Crescent Biopharma CFO Richard William Scalzo Sells $10.2K of Stock

Richard William Scalzo, CFO, sold 568 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $10.2K in total on Sep 16, 2026. Shares held after the trade: 19,730 (-2.8%).

Value
$10.2K
Shares
568
Price
$17.90
Role
CFO
Holding change
-2.8%
Trade date
Sep 16, 2026
4:03 PM ET Form 4
Insider Selling Crescent Biopharma, Inc. CBIO

Crescent Biopharma CEO Joshua T. Brumm Sells $160K of Stock

Joshua T. Brumm, CEO, sold 9,447 shares of Crescent Biopharma, Inc. at $16.71 to $17.90 a share (average $16.91) in 2 transactions, worth $160K in total between Sep 16, 2026 and Sep 18, 2026. Shares held after the trade: 271,765 (-2.8%).

Value
$160K
Shares
9,447
Average price
$16.91
Role
CEO
Holding change
-2.8%
Trade date
Sep 16, 2026 to Sep 18, 2026
4:03 PM ET Form 4
Insider Selling Crescent Biopharma, Inc. CBIO

Crescent Biopharma Insider Barbara Harlin Bispham Sells $11.1K of Stock

Barbara Harlin Bispham sold 620 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $11.1K in total on Sep 16, 2026. Shares held after the trade: 18,710 (-3.2%).

Value
$11.1K
Shares
620
Price
$17.90
Holding change
-3.2%
Trade date
Sep 16, 2026
4:03 PM ET Form 4
Insider Selling Kanzhun Ltd BZ

Kanzhun Insider Yang Mu Sells $453K of Stock

Yang Mu sold 60,704 shares of Kanzhun Ltd at $7.46 a share, worth $453K in total on Sep 17, 2026. Shares held after the trade: 143,356 (-29.7%).

Value
$453K
Shares
60,704
Price
$7.46
Holding change
-29.7%
Trade date
Sep 17, 2026
4:03 PM ET Form 4
Insider Selling Proto Labs Inc PRLB

Proto Labs CFO Daniel Schumacher Sells $418K of Stock

Daniel Schumacher, CFO, sold 4,900 shares of Proto Labs Inc at $85.21 a share, worth $418K in total on Sep 17, 2026. Shares held after the trade: 40,019 (-10.9%).

Value
$418K
Shares
4,900
Price
$85.21
Role
CFO
Holding change
-10.9%
Trade date
Sep 17, 2026
4:02 PM ET 8-K
Court & Legal Update Mercury Systems Inc MRCY

Mercury Systems Court & Legal Update

Mercury Systems received preliminary court approval for the settlement of two consolidated stockholder derivative actions, Jones v. Aslett and McKinnon v. Aslett. The settlement resolves litigation originally agreed upon in July 2026, with the court issuing formal orders granting preliminary approval on September 9 and September 15, 2026.

Counterparty
Essex County Superior Court for the Commonwealth of Massachusetts
4:02 PM ET 8-K
Investor Presentation Fuel Tech, Inc. FTEK

Fuel Tech Investor Presentation

Fuel Tech, Inc. has posted an updated corporate presentation to its website and filed it as an exhibit to this 8-K. The presentation, dated September 14, 2026, provides a strategic overview of the company's operations and technology for investors.

4:02 PM ET 8-K
Dividend Omega Flex, Inc. OFLX

Omega Flex Dividend

Omega Flex, Inc. declared a regular quarterly cash dividend of $0.34 per share for the third quarter of 2026. The dividend is payable on October 14, 2026, to shareholders of record as of the close of business on September 30, 2026.

4:02 PM ET 8-K
Capital Raise KKR FS Income Trust

KKR FS Income Trust Capital Raise of $3.71M

KKR FS Income Trust issued and sold 127,341.992 Class I shares for approximately $3.705 million as part of its ongoing continuous private offering. The company also reported a net asset value (NAV) per share of $29.10 as of August 31, 2026, with total offering proceeds to date reaching approximately $1.769 billion.

Value
$3.71M
Counterparty
Participating investors
4:01 PM ET 8-K
Capital Raise Zoomcar Holdings, Inc. ZCAR

Zoomcar Holdings Capital Raise

Zoomcar Holdings, Inc. completed the sixth closing of its private placement of Series A units, raising approximately $155,000 in gross proceeds. Each unit, sold at $1,000, consists of one share of Series A Convertible Preferred Stock and a warrant to purchase 20,000 shares of common stock. The company has agreed to file a registration statement for the resale of the underlying common stock within 15 days of the closing.

Counterparty
certain accredited investors
4:01 PM ET 8-K
Dividend Carlyle Credit Solutions, Inc.

Carlyle Credit Solutions Dividend

Carlyle Credit Solutions declared a quarterly dividend of $0.14 per share for Class I common stock, payable on October 28, 2026. The company also disclosed it raised $10.3 million through the issuance of 569,592 shares as part of its ongoing continuous private offering and reported a net asset value (NAV) per share of $18.05 as of August 31, 2026.

4:01 PM ET 8-K
Dividend Mesa Royalty Trust MTR

Mesa Royalty Trust Dividend

Mesa Royalty Trust announced that there will be no cash distribution for the month of September 2026. The suspension is due to costs and expenses exceeding royalty revenues from its oil and gas properties, as well as the Trust's ongoing effort to build a $2.0 million cash reserve for liquidity.

Term
September 2026
4:01 PM ET 8-K
Dividend Cemtrex Inc CETX

Cemtrex Dividend

Cemtrex Inc. announced that its Board of Directors has authorized the payment of a semi-annual dividend on its Series 1 Preferred Stock in the form of additional shares of the same stock. The dividend is based on a 10% annual rate on a $10.00 per share preference amount and will be issued on October 7, 2026, to shareholders of record as of September 30, 2026.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.